Digital health: Aptar Pharma acquires the assets of Cohero Health

AptarGroup announces that it has acquired all operating assets and the proprietary portfolio of Cohero Health, a digital therapeutics company transforming respiratory disease management for asthma and chronic obstructive pulmonary disorder (COPD). Founded in 2013, New York-based Cohero Health develops innovative digital tools and technologies to improve respiratory care, reduce avoidable costs and optimize medication utilization.

With this transaction, Aptar Pharma acquires Cohero Health’s turnkey digital health platform and device assets including:

• BreatheSmart® Connect digital health platform – a care coordination and HIPAA-compliant SaaS cloud service which captures and securely stores data from Cohero Health’s devices and BreatheSmart® software for remote monitoring and patient communications to help manage patient therapy;

• BreatheSmart® App – designed for patient habit creating and behavior change, driving appropriate medication utilization. Provides real-time tracking of medication adherence and lung function, along with reminders, educational materials and symptom/trigger recording;

• HeroTracker® Sensors – Bluetooth enabled medication smart inhaler sensors designed for both control and rescue medications. Attaches to respiratory medications to automatically record time and date of doses taken;

• mSpirometer™ and cSpirometer™lung function diagnostic sensors – enables comprehensive pulmonary lung function testing in a handheld wireless device.

Adding digital solutions to current treatments and therapies provides a mechanism for patients and health care providers to better manage disease conditions by providing seamless integration between disease management solutions and therapies. In addition, health care providers are able to better monitor their patients in real-time and make more informed decisions to improve standard of care. “Cohero Health further strengthens and expands Aptar’s digital portfolio, in this case, with a focus in respiratory disease management,” commented Sai Shankar, Aptar Pharma’s Vice President, Global Digital Healthcare Systems. “Aptar has made previous investments in digital respiratory company Sonmol in China and digital health company Navia Life Care in India. With this strategic bolt on, Aptar now has global capabilities to deploy digital respiratory health, utilizing either the Cohero or Aptar device portfolio/platform. The investment will also facilitate Aptar’s ability to provide diagnostic solutions in respiratory and a significant number of other disease categories.”

All rights reserved except agreement written by Emballage Digest or mention of the magazine